10. Cardiovascular Risk in Chronic Kidney Disease

Por Lainščak, Mitja
Publicado no EJIFCC (2009)

How to Improve Adherence to Life-saving Heart Failure Treatments with Potassium Binders

Por Lainscak, Mitja
Publicado no Card Fail Rev (2017)

ACT‐ONE ‐ ACTION at last on cancer cachexia by adapting a novel action beta‐blocker

Por Lainscak, Mitja, Laviano, Alessandro
Publicado no J Cachexia Sarcopenia Muscle (2016)

Heart failure, chronic obstructive pulmonary disease, and asthma: numbers, facts, and challenges

Por Lainscak, Mitja, Anker, Stefan D.
Publicado no ESC Heart Fail (2015)

Heart failure and chronic obstructive pulmonary disease: Two for tea or tea for two?

Por Suskovic, Stanislav, Kosnik, Mitja, Lainscak, Mitja
Publicado em 2010

Cytokine Response of Cultured Skeletal Muscle Cells Stimulated with Proinflammatory Factors Depends on Differentiation Stage

Por Podbregar, Matej, Lainscak, Mitja, Prelovsek, Oja, Mars, Tomaz
Publicado em 2013

Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary disease

Por Roblek, Tina, Trobec, Katja, Mrhar, Ales, Lainscak, Mitja
Publicado no Arch Med Sci (2014)

Cardiovascular Function in Intensive Care Medicine or Homo Mensura Est

Por Lainscak, Mitja, Molnar, Zsolt, Monnet, Xavier, Voga, Gorazd
Publicado no Biomed Res Int (2016)

Echocardiography and cardiac biomarkers in patients with non-small cell lung cancer treated with platinum-based chemotherapy

Por Omersa, Daniel, Cufer, Tanja, Marcun, Robert, Lainscak, Mitja
Publicado no Radiol Oncol (2016)

Comorbidities in Chronic Obstructive Pulmonary Disease from Assessment to Treatment

Por Clini, Enrico M., Boschetto, Piera, Lainscak, Mitja, Janssens, Wim
Publicado em 2014

Growth hormone, insulin-like growth factor 1, and insulin signaling—a pharmacological target in body wasting and cachexia

Por Trobec, Katja, von Haehling, Stephan, Anker, Stefan D., Lainscak, Mitja
Publicado em 2011

The obesity paradox in chronic disease: facts and numbers

Por Lainscak, Mitja, von Haehling, Stephan, Doehner, Wolfram, Anker, Stefan D.
Publicado em 2012

Emerging Biomarkers in Heart Failure and Cardiac Cachexia

Por Loncar, Goran, Omersa, Daniel, Cvetinovic, Natasa, Arandjelovic, Aleksandra, Lainscak, Mitja
Publicado no Int J Mol Sci (2014)

Cardiac cachexia: hic et nunc

Por Loncar, Goran, Springer, Jochen, Anker, Markus, Doehner, Wolfram, Lainscak, Mitja
Publicado no J Cachexia Sarcopenia Muscle (2016)

Exercise-Induced Changes in Iron Status and Hepcidin Response in Female Runners

Por Auersperger, Irena, Škof, Branko, Leskošek, Bojan, Knap, Bojan, Jerin, Aleš, Lainscak, Mitja
Publicado em 2013

Fluid Therapy: Double-Edged Sword during Critical Care?

Por Benes, Jan, Kirov, Mikhail, Kuzkov, Vsevolod, Lainscak, Mitja, Molnar, Zsolt, Voga, Gorazd, Monnet, Xavier
Publicado no Biomed Res Int (2015)

Pharmacokinetics of Drugs in Cachectic Patients: A Systematic Review

Por Trobec, Katja, Kerec Kos, Mojca, von Haehling, Stephan, Springer, Jochen, Anker, Stefan D., Lainscak, Mitja
Publicado em 2013

Impact of chronic inflammatory airway disease on stroke severity and long-term survival after ischemic stroke - a retrospective analysis

Por Haeusler, Karl Georg, Herm, Juliane, Konieczny, Maria, Grittner, Ulrike, Lainscak, Mitja, Endres, Matthias, Doehner, Wolfram
Publicado no BMC Neurol (2015)

Single baseline serum creatinine measurements predict mortality in critically ill patients hospitalized for acute heart failure

Por Schefold, Joerg C., Lainscak, Mitja, Hodoscek, Lea Majc, Blöchlinger, Stefan, Doehner, Wolfram, von Haehling, Stephan
Publicado no ESC Heart Fail (2015)

Cachexia as a major public health problem: frequent, costly, and deadly

Por Farkas, Jerneja, von Haehling, Stephan, Kalantar-Zadeh, Kamyar, Morley, John E., Anker, Stefan D., Lainscak, Mitja
Publicado em 2013